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In an effort to better understand the consequences of lead 
(Pb’+) on skeletal growth, the effects of Pb*+ were investigated 
using ROS 17/2.8 bone-like cells in vitro. These studies revealed 
that Pb2+ (4.5 X 10m6 M - 4.5 X 10M7 M) has little or no effect 
on cell shape except when added immediately following seeding 
of the cells. However, proliferation of ROS cells was inhibited, 
in the absence of serum, at concentrations of 4.5 X 10m6 M Pb*+. 
Protein production was generally increased, however, the major 
structural protein of bone, type I collagen, production was only 
slightly altered. Following treatment of ROS cells with Pb*+, 
intracellular levels of the calcium-binding protein osteonectin/ 
SPARC were increased. Osteonectin/SPARC secretion into the 
media was delayed or inhibited. Coincident with retention of 
osteonectin/SPARC there was a decrease in the levels of osteo- 
nectin/SPARC mRNA as determined by Northern analysis. 
These studies suggest that processes associated with osteonectin/ 
SPARC translation and secretion are sensitive to Pb2+. o 1992 
Academic Press, Inc. 
Lead (Pb”) is a toxic substance that is known to impair 
skeletal growth even at levels of exposure for the general 
population (0.75 PM) (Mooty et al., 1975; Angle and Huse- 
man, 1989; Shukla et al., 1989; Schwartz et al., 1986; Fri- 
sanch and Ryan, 1991). There are several indications that 
Pb2+ by its interactions with calcium (Ca2+) may perturb 
many normal calcium regulatory processes, e.g., its action 
as a second messenger, interactions with calcium binding 
and other extracellular proteins associated with mineralized 
tissues and subcellular functions at the level of the mito- 
chondria, synaptosomes, and membrane vesicles. Further- 
more, lead is known to affect protein synthesis (Shelton et 
al., 1986), particularly by increasing proteins that constitute 
nuclear and cytoplasmic inclusion bodies (Moore et al., 1973; 
Richter et al., 1968; Choie et al., 1975; McLachlin et al., 
1980; Shelton and Egle, 1982), two glucose regulated proteins 
(Shelton et al., 1986) and by deminishing the levels of the 
bone related protein, osteocalcin (Angle et al., 1990; Long 
et al., 1989, 1990). 
In addition to osteocalcin, there is increasing evidence 
that other noncollagenous proteins associated with miner- 
alized tissues play a critical role in the regulation of osteo- 
genesis. This has led to increased research emphasis on pu- 
rifying, characterizing, and identifying the role of these pro- 
teins in the mineralization process (for reviews see Butler 
1985; Fisher et al.. 1987; Glimcher and Lian, 1989). Many 
of these proteins are acidic and are known to bind both Ca2+ 
and hydroxylapatite, suggesting a role for them in the initial 
phases of mineralization. Also, some bone related proteins 
such as osteonectin/SPARC (secreted protein, acid and rich 
in cysteine) mRNA have been localized to areas of active 
tissue morphogenesis and are expressed in cells and tissues 
that exhibit high rates of turnover, secretion, and remodeling 
(Funk and Sage, 199 1). In the studies reported here we seek 
to determine if Pb2+ alters the characteristics of ROS 17/2.8 
bone-like cells in vitro. Also, this study determines whether 
Pb2+ affects the production of two recognized bone matrix 
components, collagen and osteonectin/SPARC. Further- 
more, we examine the effect of Pb2+ on Hsp47, a resident 
endoplasmic reticulum protein of cells producing type I col- 
lagen (Nakai et al., 1990; Sauk et al., 1990b). 
MATERIALS AND METHODS 
Cell culture. Cloned bone cell lines (ROS 17/2.8) derived from AC19935 
rat osteosarcoma were used. These cells have the advantage that their os- 
teoblastic-like phenotypic characteristics are maintained in vitro (Majeska 
et al.. 1980). Cells were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 1.16 g/l glutamine, 100 units/ml penicillin, 
100 &ml streptomycin, and 10% fetal bovine serum (FBS). Lead glutamate 
was prepared by preparing a stock solution containing 4.5 X lo-’ M lead 
nitrate (Sigma) and 5.0 X lo-’ M glutamic acid in water. 
Proliferation rate. To evaluate the effects of lead on cell proliferation, 
ROS 17/2.8 cells were seeded into tissue culture wells (35 mm Falcon), 
0041-008X/92 $5.00 
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~8.0 X lo3 cells/well. with DMEM supplemented with 10% FBS and an- 
tibiotic and incubated overnight at 37°C. On the following day, the medium 
was removed from each well and medium added as follows: (a) DMEM + 
10% FBS + glutamic acid; (b) DMEM + 2% FBS + glutamic acid; (c) DMEM 
+ 0% FBS + ghrtamic acid; (d) DMEM + 2% FBS t lead glutamate; and 
(e) DMEM t 0% FBS + lead glutamate. The effects of lead glutamate on 
cell proliferation were evaluated at three different concentrations, 4.5 X lo-’ 
M, 4.5 X 10m6 M and 4.5 X lo-’ M. Cell proliferation, on Day 2, Day 4. and 
Day 6 after seeding, was determined by trypsinizing cells and counting elec- 
tronically using a Coulter counter. 
Determination of total protein and collagen production. The methods 
for labeling cells have been reported previously (Somerman et al.. 1987). 
Briefly, 1.0 X lo4 cells per test well (Falcon, 35-mm wells) were seeded in 
wells in DMEM with 10% FBS and antibiotics. After cells attached and 
spread, medium was removed and cells were incubated for 48 hr in serum- 
free DMEM with 20 &i/ml L-5-[3H]proline and (a) glutamic acid (control) 
or(b) 4.5 X 1O-6 M lead glutamate. Media and cell samples were then dialyzed 
extensively against cold buffer (pH 7.4,0.05 M Tris-HCI, 0.2 M NaCI, 0.005 
M CaCl,). Following dialysis, aliquots of these samples were counted in a 
liquid scintillation spectrometer (Packard Tri Carb 460C) in Aquasol- (New 
England Nuclear (NEN) Boston. MA). These counts represented total non- 
dialyzable radioactive material and were taken as a measure of total protein 
production. 
To estimate collagen production, an ahquot of the above dialyzed material 
was reacted for 6 hr at 37°C with chromatographicahy purified bacterial 
collagenase (Form III, Advance Biofactures) according to methods of Pe- 
terkofsky and Diegelmann ( 197 1). Undigested proteins were precipitated 
with 5% trichloroacetic acid/0.5% tannic acid and samples were centrifuged. 
An aliquot of the supernatant was counted in Aquasol- (NEN) with a liquid 
scintillation counter. To provide a background value for the collagenase 
assays, additional aliquots of dialyzate were treated as above except that 
bacterial collagenase was excluded from these samples. The resulting back- 
grounds were subtracted from the collagenase-treated series to yield a value 
which represented collagen production expressed as collagenase digestible 
protein. 
To determine the effects of lead on protein synthesis, cells were incubated 
with 35S-methionine and 4.5 X 10m6 M lead glutamate for 20 min and then 
cell and media were harvested separately, as described above. Nonradioactive 
wells were run in parallel with these experiments to obtain total number of 
cells/well at time of harvest. The cells were harvested with 0.08% trypsin/ 
0.04% EDTA and total cell number per well was determined electronically 
by Coulter counter. All assays were run in triplicate and data expressed as 
CPM X I Om3/ 1 O6 cells. 
Gel electrophoresis. For polyacrylamide gel electrophoresis (PAGE), cells 
were seeded and exposed to 4.5 X 1 Om6 M lead glutamate and radioactively 
labeled exactly as described above. Media and cell samples were dialyzed 
extensively against distilled water and lyophilized. Comparable cell and media 
samples, of control and lead-treated cells. were dissolved in gel buffer. Thus, 
any variation in protein profiles among samples is based on altered protein 
production/well during the labeling period. Following reduction with mer- 
captoethanol, the samples were analyzed by gel electrophoresis on SDS 4- 
20% polyacrylamide gradient slab gels according to the method of Laemmli 
(1970). The gels were fixed, dried, and autoradiographed using the method 
of Bonner and Laskey (1974). 
Zmmunoblotting. For Western blots. 3 X lo6 cells were plated and SDS- 
PAGE was performed as described above and proteins were immediately 
electrotransferred to nitrocellulose paper (Towbin et al., 1979). The paper 
was blocked with 3% bovine serum albumin (BSA) in 10 mM Tris-HCl, pH 
7.4.0.9 M NaCl (TBS) for 1 hr and then in TBS/BSA with 2% normal goat 
serum (NGS-GIBCO). Antiserum, rabbit-anti-bovine osteonectin (gift of L. 
Fisher NIDR/NIH), or preimmune serum were diluted 1:2000 in the same 
solution and incubated with gentle shaking overnight. The nitrocellulose 
paper was then rinsed three times for 5 min in TBS/Tween. The secondary 
antibody, affinity-purified goat-anti-rabbit IgG (Fc) horseradish peroxidase 
(Kirkegaard & Perry Labs, Inc., Gaithersburg, MD) was diluted to 0.9 pg/ 
ml and incubated with the paper for 2 hr. Washing between steps was per- 
formed three times for 30 min with 50 mM Tris-HCl, 0.9 M NaCI, 0.05% 
Tween, pH 7.4. Staining was accomplished with 4-chloro-naphthol. For 
Hsp47, polyclonal rabbit antibodies were prepared against a 22-mer peptide 
corresponding to the N-terminal sequence of chick Hsp47 (Hirayoshi et al.. 
199 1) that was conjugated to Keyhole limpit hemocyanin (Sauk et al., 1990b). 
Zmmunoprecipitation. Cell layers having equal cell numbers were ho- 
mogenized in 2X immunoprecipitation buffer (0.2 M Tris-HCI, 0.3 M NaCl., 
2% Triton X-100, 2% deoxycholate, 0.2% SDS, pH 7.2) and diluted with 
cold distilled water to 1 X. while the culture media was diluted 3: 1 with 4X 
immunoprecipitation buffer. The homogenates and media were then cen- 
trifuged for 5 min at 10,OOOg in an Eppendorfcentrifuge and a 50-r] sample 
of the radiolabeled supernatant was added to a mixture of GammaBind G- 
Agarose (Genex, Gaithersburg, MD) and antibody in PBS-azide. The samples 
were then incubated at 4°C with constant shaking and then centrifuged at 
10,OOOg for 10 min. The resulting immunoprecipitate pellets were then 
washed twice with PBS-azide. The final pellets were suspended in 2X gel 
electrophoresis sample buffer, heated for IO min at 90°C. and then centrifuged 
to remove GammaBind G-agarose. Samples ofthe supematants were counted 
in a scintillation counter and another sample analyzed by PAGE and au- 
toradiography as described above. Autoradiograms were densitometrically 
scanned and data were reported as ratio of treated to control samples. 
Northern analysis. Total RNA from 4 X lo6 ROS 17/2.8 cells was sol- 
ubilized in 500 ~14 M guanidinium thiocyanate containing 25 mM sodium 
acetate (pH 5.0) and 100 IIIM fl-mercaptoethanol, transferred to an Eppendorf 
tube containing 20-pg of calf liver tRNA, and precipitated by addition of 
450 r.d of 100% ethanol. RNA pellets were reprecipitated in the presence of 
80% ethanol containing 100 mM sodium acetate (pH 5.0) at -20°C. and 
equal amounts of RNA were immediately loaded onto Northerns. RNA 
was transferred to nitrocellulose and bound to the paper by baking at 80°C 
for 2 hr in YYZUU. A 1.5-kb EcoRI restriction fragment of a bovine osteonectin 
cDNA (Sauk et al.. I99 1) was radiolabeled by nick translation (Amersham 
Kit) using cu-[P3’] dCTP and hybridized to filter bound RNA. Hybridization 
was carried out at 37°C in a mixture of 40% formamide, 0.1 g/ml dextran 
sulfate, 5X SSC (74 mM sodium citrate, 750 mM sodium chloride), 10 mM 
Tris (pH 7.5). 4X Denhardt’s solution, and 0.1 mg/ml denatured salmon 
sperm DNA. The filters were washed in a solution of 2X SSC. 0.1% SDS 
three times for I5 min at 25°C and autofluorographed. Values of the osteo- 
nectin/SPARC mRNA (arbitrary densitometric units) were normalized to 
the amount of ribosomal RNA. 
Attachment assay. The attachment assay utilized is similar to that of 
Klebe (1974). Uncoated polystyrene bacteriological 24-well plates (bacte- 
riological petri dishes. 25820 special Corning) containing the specific factor 
being evaluated. i.e., fibronectin (10 &ml, positive control) or lead glutamate 
at a concentration of 4.5 X 10e6 M and 4.5 X lo-’ M, were preincubated 
for 1 hr at 37°C in 0.4 ml DMEM containing I mg/ml bovine serum albumin 
(BSA, Fraction V Miles Laboratories, Inc.). Control wells had DMEM plus 
BSA. Following the conditioning period ROS 17/2.8 cells. at a concentration 
of 3 X IO“ cells in 0.1 ml of DMEM/BSA were added to the wells. Incubation 
was continued for an additional 90 min and wells were rinsed with Hanks’ 
balanced salt solution to remove unattached cells. Photographs, as needed, 
were taken at this time to document cell spreading. Cells remaining were 
removed enzymatically with 0.08% trypsin/0.04% EDTA and counted elec- 
tronically using a Coulter counter. 
Cell spreading. Cell spreading was determined by photographing six 
representative microscopic fields at X10. The photographic images were 
then captured using an ELM0 visual presenter (EV-368) and the shape of 
the resulting cells was determined following image analyses using NIH Image 
( I .40) software. 
Statistical analyses. All experiments consisted of at least triplicate de- 
terminations. The statistical significance of differences in effects of Pb2+ on 
cells was determined by analysis of variance and Duncan’s multiple range 
test. 
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RESULTS TABLE 1 
Effect of Lead on Attachment of ROS 1712.8 Cells 
Initially, lead acetate and lead glutamate were both eval- 
uated for use in these in vitro assays. Lead acetate added to 
DMEM, at comparable doses to lead glutamate ( lop5 M), 
resulted in the formation of an immediate visible precipitate. 
No visible precipitate was noted in lead glutamate solutions, 
including the 4.5 X lo-* M stock solution. Thus, lead glu- 
tamate was selected for use in determining the effects of Pb2+ 
on bone cells, in vitro. 
For proliferation studies cells were exposed to three con- 
centrations of Pb2+, 4.5 X 10e5 M, 4.5 X 10m6 M, and 4.5 X 
10m7 M in DMEM/2% FBS or DMEM/O% FBS. After 1 day 
exposure of cells to 4.5 X 10m5 M Pb2+ in DMEM/O% FBS 
a visible precipitate was noted. By Day 4 a similar precipitate 
was noted in cells exposed to 10e5 M Pb2+ in DMEM/2% 
FBS and a decrease in cell proliferation was noted compared 
to controls (Fig. 1). Concentrations of Pb*+ less than 4.5 X 
10e5 M had no effect on cell proliferation in the presence of 
serum. However, in the absence of serum, 4.5 X 10m7 M Pb*’ 
increased cell proliferation at Day 4 while, 4.5 X 10e6 M 
Pb*+ inhibited proliferation, but not until Day 6. 
The in vitro attachment assay revealed that Pb2+ (4.5 X 
lop6 M-4.5 X lo-* M) did not affect cell attachment. Fur- 
thermore, fibronectin attached cells were not displaced by 
the addition of Pb*+ to the media (Table 1). However, if Pb*+ 
(4.5 X 10m6 M) was incorporated into the medium of cells 
within the first 3 hr, 92 ? 3% the cells that attached did not 
go on to spread (Fig. 2A). This nonspread condition persisted 
for up to 4 days, after which the experiment was terminated. 
LEAD CONCENTRATION (Ml 
(DAY 2) (DAY 4) (DAY 6) 
Treatment 







Na glutamate (0.5 X lo-’ M) 
Pb glutamate (4.5 X lo-’ M) 
Pb glutamate (4.5 X 10m6 M) 
Pb glutamate (4.5 X IO-’ M) 
Na glutamate (5.0 X 10e5 M) + FN 
Pb glutamate (4.5 X 10m5 M) + FN 
Pb glutamate (4.5 X 10m6 M) + FN 
Pb glutamate (4.5 X lo-’ M) + FN 
960 f  236 
15407 * 13454 
1009 f  130 
1073 + 301 
1062 -c 415 
1083 -I 108 
16622 + 2043” 
14529 rt 1366” 
14220 k 1038” 
15189 f  2503” 
3.2 f  0.8 
51.4 + 4.5 
3.4 * 0.4 
3.6 f  1.0 
3.5 f  1.4 
3.6 + 0.4 
55.4 It 6.8 
48.4 + 4.5 
47.4 + 3.5 
50.6 f  8.3 
“p < 0.05 when compared with control wells. 
Note. FN, fibronectin. All agents were evaluated in triplicate and data 
expressed as number of cells attached + SD (3.0 X 10“ cells per well were 
applied). There were day to day variations in the number of cells applied. 
For clarity and consistency results are expressed as the number of cells at- 
tached per well k SD. 
If the cells were allowed to attach and spread overnight, Pb*+ 
added to the medium did not affect spreading, consequently 
85 * 9% of Pb2+ treated and 87 + 6% of control cells were 
noted to spread (Fig. 2). 
Based on proliferation and attachment results, Pb*+ at 4.5 
X lop6 M was added 24 hr after plating and used in assays 




















LEAD CONCENTRATION (M) 
(DAY 2) (DAY 4) (DAY 6) 
FIG. I. The effect of lead glutamate (4.5 X lo-‘-4.5 X lo-’ M) in the absence (A) and presence (B) of 2% fetal bovine serum on the proliferation of 
ROS 17/2.8 cells. Data represent the mean of three determinations f  the standard deviation (T). *Indicates significantly (p = 0.05) different from control 
by ANOVA. 
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FIG. 2. (A) Attached and rounded (unspread) ROS 17/2.8 cells treated with 4.5 X 10T6 M Pb*+ 3 hr after plating. Cells were then maintained for an 
additional 21 hr in a humidified atmosphere as described under Materials and Methods. (B) Attached and spread ROS 17/2.8 cells that were treated with 
4.5 X 10m6 M Pb*+ 12 hr after plating. Cells were then maintained for an additional 12 hr in a humidified atmosphere as described under Materials and 
Methods. (C) Control cells grown for 24 hr as described under Materials and Methods. Results represent the mean of four separate experiments. 
tivity of ROS 17/2.8 cells, in vitro. Both media and cells nificant increase in collagen production was observed (Table 
exposed to Pb2+ for 48 hr exhibited a significant increase in 2). To determine whether Pb2+ had a short-term effect on 
total protein production/cell, approximately 30 and 40%, cellular proteins (i.e., protein synthesis) ROS 17/2.8 cells 
respectively, when compared to control. In contrast, no sig- were exposed to 4.5 X 10e6 M Pb2+ for 20 min and radio- 
TABLE 2 TABLE 3 
Effect of Lead Glutamate on Protein and Collagen Effect of Lead Glutamate on Protein Synthesis 
Production by ROS 17/2.8 Cells by ROS 17/2.8 Cells 
Total protein production Collagen production Total protein synthesis 
(CPM X lo-‘) (CPM X 10-3) (CPM x 10-3) 
Cell Cell 
Control 708 + 86 67+ 15 Control 357 + 51 
Lead 990 + 78* 96 f  33 Lead 431 F 54* 
Media Media 
Control 540 f  42 158 f  17 Control 35* 9 
Lead 698 + 61* 169 k 25 Lead 33* 5 
Note. Cells labeled with [3H]proline were exposed to lead glutamate for Note. r5S-methionine and 4.5 X 10m6 M lead glutamate were added to 
48 hr at a concentration of 4.5 X 10m6 M. Results are expressed as means f  wells for 20 min and then media and cells were harvested separately. Results 
standard deviation. These results were representative of three separate ex- are expressed as means k standard deviation. These results were representative 
periments. of three separate experiments. 
* p < 0.05 signticantly from control wells. * p < 0.05 significantly different from control wells. 
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actively labeled during this time period. As seen in Table 3, 
Pb2+ exposed cells exhibited an increase in protein synthesis, 
but not in secreted (media) proteins. 
To further investigate these changes, we analyzed the effect 
of varying Pb2+ concentrations on cellular levels of Hsp47, 
a collagen-binding glycoprotein associated with collagen as- 
sembly and sorting, and on the acidic bone-related protein, 
osteonectin/SPARC. Hsp47 levels, as with collagen produc- 
tion, were not altered by Pb2+ treatment (Fig. 3). Conversely, 
cellular levels of osteonectin were noted to be enhanced fol- 
lowing Pb2+ exposure (Fig. 4). Examination of the media 
following Pb2+ (4.5 X low6 M) treatment revealed that os- 
teonectin/SPARC levels were not detectable, by optical den- 
sity comparison, to that of control cells (Fig. 5). Exposure 
of ROS 17/2.8 cells to 4.5 X 10p5-4.5 X 10e7 M Pb2+ for a 
shorter duration (20 min) followed by immunoprecipitation 
of cell proteins with anti-osteonectin antibodies revealed a 
dose-dependent decrease in synthesis of osteonectin/SPARC 
(Fig. 6). Northern analysis of osteonectin mRNA (2.2 kb) 
showed no differences between Pb*+ treated (4.5 X lop6 M) 
for 1 hr and control cells. However, if cells were exposed to 
PbZf for 24 hr, osteonectin/SPARC mRNA levels were re- 
duced by threefold compared to control cells (Fig. 7). 
DISCUSSION 
The data reported here demonstrate that Pb2+ decreases 
the proliferation of bone cells in vitro and enhances cellular 
protein production. The ability of Pb2+ to decrease ROS 17/ 
2.8 proliferation is in agreement with similar studies by Long 
et al. (1990). However, at comparable doses (4.5 X 10m6 M) 
we observe decreased cell growth by Day 6, whereas Long 
et al. did not observe decreased cell growth until Day 9. The 
reason for these differences may include the experimental 
design. Although both studies used ROS 17/2.8 cells, we 
used 0 and 2% serum whereas they used 5% serum. Higher 
serum levels may lower the concentration of unbound Pb*+ 
available to cells. We also used lead glutamate, while they 
used lead acetate which is particularly prone to form precip- 
itates (McLachlin et al., 1980). 
The importance of cell adhesion in the regulation of many 
physiological and pathological events including development, 
platelet aggregation, wound healing, and malignant invasion 
prompted us to further investigate the effects of Pb2+ on bone 
cell attachment. The adhesion of cells to a substratum, in 
vitro is frequently regulated by calcium dependent, receptor- 
ligand interactions. Thus a reasonable hypothesis for the ob- 
served decreased cell attachment would be that Pb2+, by 
competing with Ca2+ at the cellular membrane, may interfere 
with receptor-ligand interactions and subsequently cell at- 
tachment and spreading. Previous studies reported that mar- 
row cells exposed to Pb2+ ( 1 - 10 PM Pb2+) for 10 days exhib- 
ited decreased adherence to tissue culture dishes (Kowolenko 
et al., 1989). The ability for ROS 17/2.8 cells to attach, but 
ET AL. 
a b c d 
4- procollagen 
t 47 KDa 
FIG. 3. The effect of 4 hr of 4.5 X 10e6 M Pb2+ on Hsp47 in ROS 17/ 
2.8 cells. Lanes a and b represent Western blots utilizing anti-Hsp47 anti- 
bodies. Control lane a and Pb2’ treated lane b. ROS 17/2.8 cells. Hsp47 was 
enriched by binding to gelatin-Sepharose (Sauk et al., 1990) prior to PAGE. 
Lanes c (Control) and d (Pb2+ treated) represent autoradiographs of “S- 
methionine-labeled (4 hr). ROS 17/2.8 proteins immunoprecipitated with 
anti-Hsp47 antibodies. In addition to Hsp47. CY l(I) procollagen chains are 
coimmunoprecipitated with anti-Hsp47 antibodies (Nakai et al., 1990). The 
optical density of precipitates in Western blots and bands in immunopre- 
cipitate autoradiograms were determined by gel scanner as a component of 
NIH Image (I .4) software. These analyses revealed relative optical density 
differences of co.05 between control and Pb2+ treated cells. 
not spread following the early on addition of Pb2+ indicates 
that these events, in bone cells, are temporally mediated. 
Also, once spreading has developed Pb2+ cannot reverse this 
process. However, in our studies, no effect on cell attachment 
was noted in distinction to effects observed with marrow 
cells (Kowolenko et al., 1989). Furthermore, cells already 
attached through a calcium dependent integrin receptor-fi- 
bronectin interaction were not detached by doses of PbZf 
that were sufficient to alter protein production and cell pro- 
liferation. The separate modulation of cell spreading and 
proliferation has been noted previously. Funk and Sage 
( 199 1) showed that SPARC inhibited cell proliferation and 
caused cell rounding of endothelial cells. Furthermore, in- 
hibition of cell doubling was attributed to a 20-residue syn- 
thetic peptide (2.1) derived from a non-Ca2+-binding, disul- 
fide-rich region of SPARC, while cell rounding was promoted 
by sequences 5-23 in the calcium-binding region of the mol- 
ecule. In the present study, there was no secretion of osteo- 
nectin/SPARC to cause cell rounding in the first few hours. 
However, Pb2+ might alter a membrane receptor, ion pump, 
or disturb a second messenger system (Borke et al., 1988; 
Busselberg et al., 199 1) controlling cell shape. 
Lead’s ability to modulate both the synthesis and pro- 
duction of proteins by ROS 17/2.8 cells appears to be directed 
at least in part to acidic calcium binding proteins. Thus. 
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a b C d a b c 
FIG. 4. Western blot of cellular osteonectin/SPARC (43 kDa) using 
anti-osteonectin antibodies, in ROS 17/2.8 cells following exposure to various 
concentrations oflead glutamate for 4 hr. (a) control; (b) 4.5 X IO-’ M Pb2+; 
(c) 4.5 X 10m6 M Pb*+: (d) 4.5 X IO-’ M Pb2+. Lower molecular weight bands 
observed in lanes c and d were considered to represent minor alterations in 
protein processing, i.e., glycosylation or phosphorylation. Results represent 
the mean of three separate experiments. 
collagen and Hsp47 levels are unchanged whereas cellular 
levels of osteonectin/SPARC are enhanced and secretion 
similar to osteocalcin (Angle et al., 1990; Long et al., 1989, 
1990) is inhibited. However, the increased cellular levels of 
osteonectin/SPARC ensue while synthesis, depicted by short- 
term 35S-methionine labeling, is diminished. Shelton et al. 
(1986) similarly demonstrated that Pb2+ enhances the level 
of an acidic (p1 6.3) inclusion body protein in kidney cells, 
and Fowler et al. (1985) showed increases in the synthesis 
of acidic gene products in rats given a single low dose of 
Pb2+ which induced intranuclear inclusions in renal proximal 
tubule cells. However, unlike the Pb2+-induced nuclear pro- 
teins, osteonectin/SPARC is secreted, though delayed, in the 
presence of Pb2+ and is found in the medium. Lead inhibits 
this release possibly by affecting the conformation of osteo- 
nectin/SPARC as well as other acidic calcium-binding pro- 
teins. As a result, these proteins are retained in the ER. The 
inhibition or delayed secretion of structurally altered proteins 
is common and delayed synthesis, even in the presence of 
equivalent levels of mRNA, may ensue as a consequence of 
retention or delayed secretion of protein from the ER (Byers, 
1990). 
The diminished levels of osteonectin/SPARC mRNA in 
cells treated with Pb’+ for 24 hr signifies that pretranslational 
events controlling these acidic cellular proteins may also be 
FIG. 5. Immunoprecipitation of 35S-methionine-labeled (4 hr) osteo- 
nectin/SPARC (43 kDa) from the media of ROS 17/2.8 cells following 4 hr 
treatment with 4.5 X 10m6 M Pbzf and continuously labeled with 35S-me- 
thionine. (a) control; (b) 4.5 X IO-’ M Pb’+; (c) 4.5 X 10e6 M Pb*+. Results 
represent the mean of three separate experiments. 
affected by Pb2+. The accumulation, over time, of PbZf in 
the nucleus (Shelton, 1986) may place Pb*+ in proximity to 
transcriptional events. Proteins such as p2 l/6.2, associated 
with nuclear matrices, have been implied in affecting DNA 
replication, RNA transcription, mitogenesis, and cell prolif- 
eration (Mistry et al., 1985, 1986; Klann and Shelton, 1989; 
Fowler and Duval, 199 I). Candidates for posttranscription 
and/or pretranslational affects of Pb2+ include the ~220 
component of an eukaryotic initiation factor 4F and regu- 
calcin-like proteins. The ~220 component functions in the 
first step of the binding of capped mRNAs to the small ri- 
bosomal subunit and has been shown to be a substrate for 
a b C d 
FIG. 6. Immunoprecipitation of cellular osteonectin/SPARC following 
20 min treatment with various concentrations of lead glutamate. (a) control; 
(b) 4.5 X 10e5 M Pb*+; (c) 4.5 X lO-6 M Pb’+; (d) 4.5 X IO-’ M Pb’+. Results 
were reproduced in three separate experiments. 
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C a b d 
FIG. 7. Northern analysis of ROS 17/2.8 cells. Panel represents an au- 
toradiogram of ‘*P-nick-labeled bovine osteonectin cDNA hybridized to 
ROS 17/2.8 RNA migrating to 2.2 kb. (a) control cells, (b) 4.5 X 10m6 M 
Pb’+ for 1 hr, (c) control cells (24 hr), (d) 4.5 X 10m6 M Pb*+ (24 hr). Although 
equal amounts of RNA were loaded in each paring, autoradiograms of lanes 
c and d were exposed for a longer period in order to visualize lane d. Results 
were reproduced in two separate experiments. 
multiple calcium-dependent enzymes (Wyckoff et al., 1990). 
Regucalcin, a calcium-binding protein derived from cytosol, 
regulates Ca+* mediated cell function by inhibiting amino- 
acyl-tRNA synthetase activity (Yamaguchi and Mori, 1990). 
Thus. these studies demonstrate further that Pb”+ has a 
pleiotropic effect on bone cells. ER processes, possibly as- 
sociated with calcium-dependent protein folding, appear to 
be sensitive to Pb+*, resulting in retention or delayed protein 
secretion. In contrast, receptor-mediated attachment to sub- 
stratum is undisturbed by Pb2+. Future studies directed at 
establishing the mechanism for the alteration of specific bone 
proteins in cells exposed to Pb*+ are warranted and will help 
to clarify the effect of Pb2+ on bone growth and possibly 
provide a molecular marker for Pb*+ exposure in the envi- 
ronment. 
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